Fibromyalgia
📧 Sign up to get email alerts when something new happens for Fibromyalgia.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2023-05-02FDA Approved: DULOXETINE — Supplemental Application (Actavis Pharma, Inc.)
FDA approved a supplemental application from Actavis Pharma, Inc. for duloxetine under ANDA 090776, granting approval for a supplemental cha…
-
FDA approval · 2023-05-02FDA Approved: DULOXETINE — Supplemental Application (Solco Healthcare US, LLC)
The FDA approved a supplemental application for duloxetine submitted by Solco Healthcare US, LLC (ANDA206653), authorizing a change related …
-
CLINICAL_TRIALS trial_result · 2023-04-28Clinical Trial Update: Efficacy and Safety of NYX-2925 in Subjects With Fibromyalgia [Phase 2]
Phase 2 clinical trial evaluating NYX-2925 for fibromyalgia results completed with posted results.
-
CLINICAL_TRIALS trial_result · 2023-04-14Clinical Trial Update: The Innate Central Nervous System Immune Response to an Experimental Immune Challenge in People With Fibromyalgia [Phase 2, Phase 3]
A phase 2/3 trial evaluating the innate central nervous system immune response to an experimental immune challenge in people with fibromyalg…
-
FDA approval · 2023-03-31FDA Approved: PREGABALIN — Supplemental Application (ScieGen Pharmaceuticals, Inc)
The FDA approved a supplemental application from ScieGen Pharmaceuticals, Inc. for a generic pregabalin product. The approval covers the sam…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2023-03-30Clinical Trial Update: A Study to Test the Effectiveness and Safety of Fremanezumab on Participants With Fibromyalgia [Phase 2]
Phase 2 trial assessing fremanezumab for fibromyalgia was terminated; results posted.
-
FDA approval · 2023-03-24FDA Approved: PREGABALIN — Supplemental Application (Solco Healthcare US, LLC)
FDA approved a supplemental application for pregabalin from Solco Healthcare US, LLC under ANDA207883. The drug is indicated for neuropathic…
-
FDA approval · 2023-03-24FDA Approved: PREGABALIN — Supplemental Application (Tris Pharma Inc)
FDA approved a supplemental application for pregabalin submitted by Tris Pharma Inc.
-
CLINICAL_TRIALS trial_result · 2022-12-29Clinical Trial Update: Fibromyalgia and Naltrexone: The FINAL Study [Phase 2]
Phase 2 clinical trial update for fibromyalgia investigating naltrexone has completed.
-
FDA approval · 2022-12-23FDA Approved: SAVELLA — Supplemental Application (Allergan, Inc.)
FDA approved a supplemental application for Savella (milnacipran hydrochloride) submitted by Allergan, resulting in a labeling change for th…
-
CLINICAL_TRIALS trial_result · 2022-12-02Clinical Trial Update: A Phase 3 Study To Evaluate The Efficacy And Safety Of TNX-102 SL In Patients With Fibromyalgia [Phase 3]
Phase 3 trial evaluating TNX-102 SL for fibromyalgia has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2022-10-05Clinical Trial Update: Light Treatment to Improve Symptom Management of Fibromyalgia Syndrome [NA]
Clinical trial on light treatment for symptom management in fibromyalgia completed; results posted in 2022.
-
CLINICAL_TRIALS trial_result · 2022-10-04Clinical Trial Update: The Exercise Response to Pharmacologic Cholinergic Stimulation in Myalgic Encephalomyelitis / Chronic Fatigue Syndrome [Phase 2]
Phase 2 trial investigating the exercise response to pharmacologic cholinergic stimulation in individuals with Myalgic Encephalomyelitis/Chr…
-
CLINICAL_TRIALS trial_result · 2022-09-27Clinical Trial Update: Fibromyalgia Outcome Research Trial Evaluating Synergistic Suppression of HSV-1 [Phase 2]
Phase 2 clinical trial evaluating synergistic suppression of HSV-1 for fibromyalgia has completed.
-
CLINICAL_TRIALS trial_result · 2022-09-22Clinical Trial Update: Neuroimaging Approaches to Deconstructing Acupuncture for Chronic Pain [NA]
A completed clinical trial focusing on neuroimaging approaches to understand how acupuncture affects chronic pain, with fibromyalgia as the …
-
CLINICAL_TRIALS trial_result · 2022-09-16Clinical Trial Update: Evaluate the Efficacy and Safety of NYX-2925 in Subjects With Fibromyalgia [Phase 2]
Phase 2 trial updates the efficacy and safety of NYX-2925 in fibromyalgia, with results posted after completion.
-
FDA approval · 2022-09-01FDA Approved: PREGABALIN — Original Application (Solco Healthcare US, LLC)
FDA approved Solco Healthcare US, LLC's original ANDA for pregabalin (generic pregabalin). This marks the approval of a generic version of p…
-
CLINICAL_TRIALS trial_result · 2022-08-26Clinical Trial Update: Dextromethorphan in Fibromyalgia [Phase 2]
Phase 2 clinical trial investigating dextromethorphan for fibromyalgia has completed with results posted in 2022.
-
CLINICAL_TRIALS trial_result · 2022-08-08Clinical Trial Update: A Study To Evaluate The Efficacy And Safety Of TNX-102 SL In Patients With Fibromyalgia [Phase 3]
Phase 3 clinical trial evaluating TNX-102 SL for fibromyalgia has completed and results were posted in 2022.
-
FDA approval · 2022-07-29FDA Approved: DULOXETINE — Supplemental Application (Quallent Pharmaceuticals Health LLC)
FDA approved a supplemental application for duloxetine filed by Quallent Pharmaceuticals Health LLC.
-
FDA approval · 2022-07-26FDA Approved: DULOXETINE — Supplemental Application (Quallent Pharmaceuticals Health LLC)
The FDA approved a supplemental application for DULOXETINE submitted by Quallent Pharmaceuticals Health LLC. The notice confirms regulatory …
-
FDA approval · 2022-07-18FDA Approved: PREGABALIN — Original Application (MARKSANS PHARMA LIMITED)
FDA approved the original ANDA for pregabalin from Marksans Pharma Limited (ANDA216197).
-
CLINICAL_TRIALS trial_result · 2022-06-21Clinical Trial Update: Efficacy of the Quell Wearable Device for Fibromyalgia [NA]
Clinical trial update reporting completed status and posted results for the Quell wearable device in fibromyalgia.
-
CLINICAL_TRIALS trial_result · 2022-06-02Clinical Trial Update: Outcomes Mandate National Integration With Cannabis as Medicine [Phase 2]
Phase 2 clinical trial update focusing on integrating cannabis as medicine for various chronic pain conditions, with status currently UNKNOW…
-
CLINICAL_TRIALS trial_result · 2022-04-11Clinical Trial Update: Neuromodulatory Effects of Transcranial Pulsed Current Stimulation in Fibromyalgia [Phase 2]
Phase 2 clinical trial investigating neuromodulatory effects of transcranial pulsed current stimulation in fibromyalgia (status unknown).